...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: MOA of Apabetalone - only affects sick patients

"Looks like there are 266 on sglt2 in BOM, so maybe 1/2 or 133 on both 208 and sglt2."

Yes, hopefully about half placebo and half apabetalone for those 266 patients in BETonMACE who are in SGLT2 inhibitor. The SGLT2 inhibitor patients are not a pre-specified subgroup in BETonMACE to my knowledge, but a post-hoc analysis can be done. No patent of apabetalone with SGLT2 inhibitors to my knowledge.

BearDownAZ

Share
New Message
Please login to post a reply